Ahead 300 is an AI-enabled medical device from BRAINSCOPE COMPANY INC, listed by FDA (510(k), K161068) with a decision date of 2016-09-22. Review panel: Neurology.
| FDA submission number | K161068 |
|---|---|
| Pathway | 510(k) |
| Company | BRAINSCOPE COMPANY INC |
| Review panel (specialty) | Neurology |
| FDA decision date | 2016-09-22 |
| Decision | Substantially Equivalent |
| Product code | PIW |
| Classification | Brain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid |
| Device class | 2 |
| Regulation number | 882.1450 |
| Review time (calendar days) | 160 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
More devices from BRAINSCOPE COMPANY INC · All Neurology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.